Literature DB >> 24820318

Drug-drug interactions and acute kidney injury: caveat prescriptor.

Mallika L Mendu1, Sushrut S Waikar2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24820318      PMCID： PMC4391370          DOI： 10.1053/j.ajkd.2014.04.015

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN： 0272-6386            Impact factor:   8.860


× No keyword cloud information.
  23 in total

1.  Impact of the drug-drug interaction database SFINX on prevalence of potentially serious drug-drug interactions in primary health care.

Authors:  M L Andersson; Y Böttiger; J D Lindh; B Wettermark; B Eiermann
Journal:  Eur J Clin Pharmacol       Date:  2012-07-01       Impact factor: 2.953

2.  Erythromycin-felodipine interaction.

Authors:  H Liedholm; G Nordin
Journal:  DICP       Date:  1991-09

Review 3.  Use of clinical decision support systems for kidney-related drug prescribing: a systematic review.

Authors:  Davy Tawadrous; Salimah Z Shariff; R Brian Haynes; Arthur V Iansavichus; Arsh K Jain; Amit X Garg
Journal:  Am J Kidney Dis       Date:  2011-09-23       Impact factor: 8.860

4.  Drug dosing consideration in patients with acute and chronic kidney disease-a clinical update from Kidney Disease: Improving Global Outcomes (KDIGO).

Authors:  Gary R Matzke; George R Aronoff; Arthur J Atkinson; William M Bennett; Brian S Decker; Kai-Uwe Eckardt; Thomas Golper; Darren W Grabe; Bertram Kasiske; Frieder Keller; Jan T Kielstein; Ravindra Mehta; Bruce A Mueller; Deborah A Pasko; Franz Schaefer; Domenic A Sica; Lesley A Inker; Jason G Umans; Patrick Murray
Journal:  Kidney Int       Date:  2011-09-14       Impact factor: 10.612

5.  A computerized provider order entry intervention for medication safety during acute kidney injury: a quality improvement report.

Authors:  Allison B McCoy; Lemuel R Waitman; Cynthia S Gadd; Ioana Danciu; James P Smith; Julia B Lewis; Jonathan S Schildcrout; Josh F Peterson
Journal:  Am J Kidney Dis       Date:  2010-08-14       Impact factor: 8.860

6.  Statin toxicity from macrolide antibiotic coprescription: a population-based cohort study.

Authors:  Amit M Patel; Salimah Shariff; David G Bailey; David N Juurlink; Sonja Gandhi; Muhammad Mamdani; Tara Gomes; Jamie Fleet; Y Joseph Hwang; Amit X Garg
Journal:  Ann Intern Med       Date:  2013-06-18       Impact factor: 25.391

7.  Pill burden, adherence, hyperphosphatemia, and quality of life in maintenance dialysis patients.

Authors:  Yi-Wen Chiu; Isaac Teitelbaum; Madhukar Misra; Essel Marie de Leon; Tochi Adzize; Rajnish Mehrotra
Journal:  Clin J Am Soc Nephrol       Date:  2009-05-07       Impact factor: 8.237

8.  The relationship between number of drugs and potential drug-drug interactions in the elderly: a study of over 600,000 elderly patients from the Swedish Prescribed Drug Register.

Authors:  Kristina Johnell; Inga Klarin
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

9.  Comparing two types of macrolide antibiotics for the purpose of assessing population-based drug interactions.

Authors:  Jamie L Fleet; Salimah Z Shariff; David G Bailey; Sonja Gandhi; David N Juurlink; Danielle M Nash; Muhammad Mamdani; Tara Gomes; Amit M Patel; Amit X Garg
Journal:  BMJ Open       Date:  2013-07-11       Impact factor: 2.692

Review 10.  Effects of chronic kidney disease and uremia on hepatic drug metabolism and transport.

Authors:  Catherine K Yeung; Danny D Shen; Kenneth E Thummel; Jonathan Himmelfarb
Journal:  Kidney Int       Date:  2013-10-16       Impact factor: 10.612
View more
  1 in total

1.  Risks of Adverse Events Following Coprescription of Statins and Calcium Channel Blockers: A Nationwide Population-Based Study.

Authors:  Yi-Chun Wang; Tsung-Cheng Hsieh; Chu-Lin Chou; Jung-Lun Wu; Te-Chao Fang
Journal:  Medicine (Baltimore)       Date:  2016-01       Impact factor: 1.817
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.